Overview

A Study to Evaluate the Pharmacokinetic Effects of Different Storage Conditions for a Long-Acting Nanosuspension of Rilpivirine on Pharmacokinetics

Status:
Completed

Trial end date:
2016-04-26

Target enrollment:

Participant gender:

Summary

The purpose of this study is to compare the single-dose pharmacokinetics of rilpivirine (RPV) after intramuscular (IM) injection of rilpivirine long-acting parenteral formulation (RPV-LA) and 'aged' RPV-LA, in healthy adult participants.

Phase:

Phase 1

Details

Lead Sponsor:

Janssen Infectious Diseases BVBA

Treatments:

Rilpivirine